2 news items
Intellia Up on Upbeat Long-Term Angioedema Study Data
ALXO
ANVS
CGEN
4 Jun 24
a single dose of NTLA-2002 in the overall patient population. Robust and sustainable reduction in HAE attack rate was observed upon treatment with all
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
NTLA
9 May 24
and Governance (ESG) principles and practices as part of its objective to build a sustainable company, while delivering on its commitments to patients
- Prev
- 1
- Next